These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation. Gasaly N; de Vos P; Hermoso MA Front Immunol; 2021; 12():658354. PubMed ID: 34122415 [TBL] [Abstract][Full Text] [Related]
4. The aryl hydrocarbon receptor as a mediator of host-microbiota interplay. Dong F; Perdew GH Gut Microbes; 2020 Nov; 12(1):1859812. PubMed ID: 33382356 [TBL] [Abstract][Full Text] [Related]
5. Optimizing therapeutic outcomes of immune checkpoint blockade by a microbial tryptophan metabolite. Renga G; Nunzi E; Pariano M; Puccetti M; Bellet MM; Pieraccini G; D'Onofrio F; Santarelli I; Stincardini C; Aversa F; Riuzzi F; Antognelli C; Gargaro M; Bereshchenko O; Ricci M; Giovagnoli S; Romani L; Costantini C J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35236743 [TBL] [Abstract][Full Text] [Related]
6. Endogenous Indole Pyruvate Pathway for Tryptophan Metabolism Mediated by IL4I1. Zhang X; Gan M; Li J; Li H; Su M; Tan D; Wang S; Jia M; Zhang L; Chen G J Agric Food Chem; 2020 Sep; 68(39):10678-10684. PubMed ID: 32866000 [TBL] [Abstract][Full Text] [Related]
7. Indole metabolites and colorectal cancer: Gut microbial tryptophan metabolism, host gut microbiome biomarkers, and potential intervention mechanisms. Liu Y; Pei Z; Pan T; Wang H; Chen W; Lu W Microbiol Res; 2023 Jul; 272():127392. PubMed ID: 37119643 [TBL] [Abstract][Full Text] [Related]
8. The Role of the Microbiome and Microbiome-Derived Metabolites in Atopic Dermatitis and Non-Histaminergic Itch. Li W; Yosipovitch G Am J Clin Dermatol; 2020 Sep; 21(Suppl 1):44-50. PubMed ID: 32910440 [TBL] [Abstract][Full Text] [Related]
9. Gut Microbial Catabolites of Tryptophan Are Ligands and Agonists of the Aryl Hydrocarbon Receptor: A Detailed Characterization. Vyhlídalová B; Krasulová K; Pečinková P; Marcalíková A; Vrzal R; Zemánková L; Vančo J; Trávníček Z; Vondráček J; Karasová M; Mani S; Dvořák Z Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32283770 [TBL] [Abstract][Full Text] [Related]
10. Indole derivatives, microbiome and graft versus host disease. Qayed M; Michonneau D; Socié G; Waller EK Curr Opin Immunol; 2021 Jun; 70():40-47. PubMed ID: 33647539 [TBL] [Abstract][Full Text] [Related]
11. Enteric formulated indole-3-carboxaldehyde targets the aryl hydrocarbon receptor for protection in a murine model of metabolic syndrome. Puccetti M; Pariano M; Borghi M; Barola C; Moretti S; Galarini R; Mosci P; Ricci M; Costantini C; Giovagnoli S Int J Pharm; 2021 Jun; 602():120610. PubMed ID: 33865951 [TBL] [Abstract][Full Text] [Related]
12. Gut-microbiota derived bioactive metabolites and their functions in host physiology. Debnath N; Kumar R; Kumar A; Mehta PK; Yadav AK Biotechnol Genet Eng Rev; 2021 Oct; 37(2):105-153. PubMed ID: 34678130 [TBL] [Abstract][Full Text] [Related]
13. Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease. Agus A; Planchais J; Sokol H Cell Host Microbe; 2018 Jun; 23(6):716-724. PubMed ID: 29902437 [TBL] [Abstract][Full Text] [Related]
14. Activation of aryl hydrocarbon receptor in Langerhans cells by a microbial metabolite of tryptophan negatively regulates skin inflammation. Liu X; Zhang X; Zhang J; Luo Y; Xu B; Ling S; Zhang Y; Li W; Yao X J Dermatol Sci; 2020 Dec; 100(3):192-200. PubMed ID: 33082071 [TBL] [Abstract][Full Text] [Related]
15. Indoles - Gut Bacteria Metabolites of Tryptophan with Pharmacotherapeutic Potential. Konopelski P; Ufnal M Curr Drug Metab; 2018; 19(10):883-890. PubMed ID: 29708069 [TBL] [Abstract][Full Text] [Related]
17. Proteomic Characterization of the Cellular Effects of AhR Activation by Microbial Tryptophan Catabolites in Endotoxin-Activated Human Macrophages. Walter K; Grosskopf H; Karkossa I; von Bergen M; Schubert K Int J Environ Res Public Health; 2021 Sep; 18(19):. PubMed ID: 34639632 [TBL] [Abstract][Full Text] [Related]
18. Pharmaceutically Active Microbial AhR Agonists as Innovative Biodrugs in Inflammation. Puccetti M; Pariano M; Costantini C; Giovagnoli S; Ricci M Pharmaceuticals (Basel); 2022 Mar; 15(3):. PubMed ID: 35337134 [TBL] [Abstract][Full Text] [Related]
19. Microbiota-derived tryptophan metabolites in vascular inflammation and cardiovascular disease. Paeslack N; Mimmler M; Becker S; Gao Z; Khuu MP; Mann A; Malinarich F; Regen T; Reinhardt C Amino Acids; 2022 Oct; 54(10):1339-1356. PubMed ID: 35451695 [TBL] [Abstract][Full Text] [Related]